SHAREHOLDER ALERT: The M&A Class Action Firm Investigates the Merger of Kronos Bio, Inc. - KRON

Core Insights - Monteverde & Associates PC is investigating Kronos Bio, Inc. regarding its proposed merger with Concentra Biosciences, LLC, where Concentra will acquire Kronos Bio for $0.57 in cash per share, plus one non-tradeable contingent value right [1] Company Overview - Monteverde & Associates PC is recognized as a Top 50 Firm in the 2024 ISS Securities Class Action Services Report and has recovered millions for shareholders [1] - The firm is headquartered in the Empire State Building, New York City, and specializes in national class action securities litigation [2] Legal Context - The firm emphasizes that no company, director, or officer is above the law, indicating a commitment to shareholder rights [3] - The firm provides free consultations for shareholders concerned about the merger or seeking additional information [3]